Merrill J. Birdno,Mike A. Schmieder,Edward E. Shaw,Brandon C. Short,Alireza Mashal,Matthew B. DeNardo,Franck J. Rubiconi,Linda M. Donoghue,Serge C. Roux
申请号：
US16583237
公开号：
US20200094018A1
申请日:
2019.09.25
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This disclosure relates generally to treatment programs utilizing expansion elements, such as those associated with occlusion and therapeutic agent delivery devices, systems, and methods. In some more specific examples, treatment programs include expansion-contraction cycles at a pre-selected frequency profile configured to treat a particular condition, such as calcification of an arterial conduit, for example.
